FR1409033T - Adhesif renfermant un medicament - Google Patents

Adhesif renfermant un medicament

Info

Publication number
FR1409033T
FR1409033T FR02752500T FR02752500T FR1409033T FR 1409033 T FR1409033 T FR 1409033T FR 02752500 T FR02752500 T FR 02752500T FR 02752500 T FR02752500 T FR 02752500T FR 1409033 T FR1409033 T FR 1409033T
Authority
FR
France
Prior art keywords
matrix
cyanoacrylate
adhesive containing
medicinal product
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR02752500T
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Loma Linda University
Original Assignee
Loma Linda University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loma Linda University filed Critical Loma Linda University
Publication of FR1409033T publication Critical patent/FR1409033T/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • A61B17/085—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound with adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0246—Adhesive bandages or dressings characterised by the skin-adhering layer
    • A61F13/0253—Adhesive bandages or dressings characterised by the skin-adhering layer characterized by the adhesive material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • A61B2017/081—Tissue approximator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR02752500T 2001-07-19 2002-07-19 Adhesif renfermant un medicament Active FR1409033T (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US30657201P 2001-07-19 2001-07-19
US30899301P 2001-07-31 2001-07-31
US33766201P 2001-11-07 2001-11-07
US34159801P 2001-12-17 2001-12-17
US10/041,688 US20030044380A1 (en) 2001-07-19 2002-01-07 Adhesive including medicament
PCT/US2002/023222 WO2003008003A1 (fr) 2001-07-19 2002-07-19 Adhesif renfermant un medicament

Publications (1)

Publication Number Publication Date
FR1409033T true FR1409033T (fr) 2007-07-20

Family

ID=27534768

Family Applications (1)

Application Number Title Priority Date Filing Date
FR02752500T Active FR1409033T (fr) 2001-07-19 2002-07-19 Adhesif renfermant un medicament

Country Status (8)

Country Link
US (1) US20030044380A1 (fr)
EP (2) EP1409033B1 (fr)
AT (2) ATE349231T1 (fr)
CA (1) CA2453620C (fr)
DE (1) DE60217121T2 (fr)
ES (2) ES2368439T3 (fr)
FR (1) FR1409033T (fr)
WO (1) WO2003008003A1 (fr)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1226019C (zh) 2000-02-24 2005-11-09 洛马林达大学医学中心 用于在手术期间闭合组织开口的补丁和胶输送系统
US7780699B2 (en) * 2000-08-02 2010-08-24 Loma Linda University Medical Center Vascular wound closure device and method
US6890342B2 (en) 2000-08-02 2005-05-10 Loma Linda University Method and apparatus for closing vascular puncture using hemostatic material
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
JP4833553B2 (ja) * 2002-11-04 2011-12-07 オーシャン・ニュートリション・カナダ・リミテッド 複数の殻を有するマイクロカプセル及びそれらの調製方法
GB0227043D0 (en) * 2002-11-20 2002-12-24 Smith & Nephew Angiogenic medical cyanoacrylate
WO2004084963A1 (fr) * 2003-03-25 2004-10-07 Smith & Nephew, Plc Adhesif medical poreux comportant du cyanonacrylate
AU2004253463B2 (en) * 2003-06-16 2010-12-09 Loma Linda University Medical Center Deployable multifunctional hemostatic agent
US8012167B2 (en) * 2003-08-14 2011-09-06 Loma Linda University Medical Center Vascular wound closure device and method
US8187627B2 (en) 2003-09-05 2012-05-29 Loma Linda University Medical Center Dressing delivery system for internal wounds
WO2005070105A2 (fr) * 2004-01-08 2005-08-04 Kevin Marchitto Lamines adhesif pour l'occlusion rapide de plaies
US8034450B2 (en) * 2005-01-21 2011-10-11 Ocean Nutrition Canada Limited Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
US20080206316A1 (en) * 2005-01-27 2008-08-28 Colin Barrow Chromium-Fatty Acid Compounds and Methods of Making and Using Thereof
EP1846355B1 (fr) * 2005-01-27 2009-12-16 Ocean Nutrition Canada Limited Derives de benzenediol d'acides gras et leurs methodes de conception et d'utilisation
US20060251612A1 (en) * 2005-05-09 2006-11-09 Dimiter Kotzev Bioresorbable cyanoacrylate adhesives
US9968120B2 (en) * 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
US8088145B2 (en) * 2005-10-05 2012-01-03 Loma Linda University Medical Center Vascular wound closure device and method
WO2007067625A2 (fr) * 2005-12-06 2007-06-14 Tyco Healthcare Group Lp Composition chirurgicale bioabsorbable
EP1957089A4 (fr) * 2005-12-06 2012-06-20 Tyco Healthcare Reticulation par carbodiimide de polyethyleneglycols fonctionnalises
WO2007067621A2 (fr) * 2005-12-06 2007-06-14 Tyco Healthcare Group Lp Compositions chirurgicales biocompatibles
EP1960469B1 (fr) 2005-12-06 2016-07-13 Covidien LP Composes bioabsorbables et compositions les contenant
WO2007067623A2 (fr) * 2005-12-06 2007-06-14 Tyco Healthcare Group Lp Adhesifs et agents de scellement tissulaires biocompatibles
US8449714B2 (en) 2005-12-08 2013-05-28 Covidien Lp Biocompatible surgical compositions
JP2009518138A (ja) * 2005-12-08 2009-05-07 タイコ ヘルスケア グループ リミテッド パートナーシップ 生体適合性外科用組成物
CA2629932C (fr) * 2005-12-08 2014-07-08 Tyco Healthcare Group Lp Compositions pulverisables a viscosite reduite
CA2643662A1 (fr) * 2006-04-07 2007-10-25 Ocean Nutrition Canada Ltd. Emulsions et microcapsules contenant des substances a faible tension interfaciale, leurs procedes de fabrication et d'utilisation
CA2651935C (fr) * 2006-05-12 2016-03-15 Entrigue Surgical, Inc. Dispositif de medialisation du cornet nasal moyen
ITRM20060289A1 (it) * 2006-05-31 2007-12-01 Ranieri Cancedda Bio membrana ingegnerizzata osteo angiogenica e suoi usi per la rigenerazione di tessuto osseo
CA2654031C (fr) * 2006-06-05 2016-05-24 Ocean Nutrition Canada Limited Microcapsules a enveloppes ameliorees
US20080109033A1 (en) * 2006-10-31 2008-05-08 Texas Heart Institute Method and device for prevention of pneumothorax during vascular access
SG175690A1 (en) 2006-11-09 2011-11-28 Kci Licensing Inc Porous bioresorbable dressing conformable to a wound and methods of making same
WO2008085997A2 (fr) 2007-01-10 2008-07-17 Ocean Nutrition Canada, Ltd. Microcapsules végétariennes
US8729121B2 (en) 2007-06-25 2014-05-20 Adhezion Biomedical, Llc Curing accelerator and method of making
US7947027B2 (en) 2007-12-28 2011-05-24 Kimberly-Clark Worldwide, Inc. Body adhering absorbent article
US8734413B2 (en) 2007-08-03 2014-05-27 Kimberly-Clark Worldwide, Inc. Packaged body adhering absorbent article
US8672911B2 (en) 2007-08-03 2014-03-18 Kimberly-Clark Worldwide, Inc. Body adhering absorbent article
EP2249884B1 (fr) 2007-11-05 2017-01-04 Technion Research & Development Foundation Ltd. Pansement adhésif et procédés d'application de ce dernier
WO2009064291A1 (fr) * 2007-11-14 2009-05-22 Spartan Medical Products, Llc Colles tissulaires à base de cyanoacrylate
US8293838B2 (en) * 2008-06-20 2012-10-23 Adhezion Biomedical, Llc Stable and sterile tissue adhesive composition with a controlled high viscosity
US8198344B2 (en) * 2008-06-20 2012-06-12 Adhezion Biomedical, Llc Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
US20110117047A1 (en) 2008-06-23 2011-05-19 Adhezion Biomedical, Llc Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
US8609128B2 (en) * 2008-10-31 2013-12-17 Adhezion Biomedical, Llc Cyanoacrylate-based liquid microbial sealant drape
US9254133B2 (en) 2008-10-31 2016-02-09 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
US8652510B2 (en) 2008-10-31 2014-02-18 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
US11147722B2 (en) * 2008-11-10 2021-10-19 Kimberly-Clark Worldwide, Inc. Absorbent article with a multifunctional acrylate skin-adhesive composition
GB2465610A (en) * 2008-11-25 2010-05-26 Ethicon Inc Medical adhesive composition comprising a alpha-cyanoacrylate monomer and a NSAID
ES2626069T3 (es) 2009-06-01 2017-07-21 Technion Research & Development Foundation Ltd. Adhesivos multicomponente, fabricación de los mismos, y aplicaciones de los mismos
US8221994B2 (en) * 2009-09-30 2012-07-17 Cilag Gmbh International Adhesive composition for use in an immunosensor
DE102010012521A1 (de) * 2010-03-17 2011-09-22 Aesculap Ag Medizinisches Kit zur Anwendung bei der Vakuumversiegelungstherapie
US20110269844A1 (en) * 2010-05-03 2011-11-03 Innoteq, Inc. Thin film with propofol active ingredient
US9309019B2 (en) 2010-05-21 2016-04-12 Adhezion Biomedical, Llc Low dose gamma sterilization of liquid adhesives
SG177871A1 (en) * 2010-07-20 2012-02-28 Agency Science Tech & Res Method and apparatus for forming a porous biodegradable medical implant device
US9586306B2 (en) 2012-08-13 2017-03-07 Omax Corporation Method and apparatus for monitoring particle laden pneumatic abrasive flow in an abrasive fluid jet cutting system
KR101477708B1 (ko) * 2013-02-13 2014-12-30 (주)시지바이오 Ｅｇｆ 마이크로스피어를 함유하는 생체 접착제 조성물
US9090808B1 (en) * 2013-03-15 2015-07-28 Omax Corporation Abrasive materials for use in abrasive-jet systems and associated materials, apparatuses, systems, and methods
US9421297B2 (en) 2014-04-02 2016-08-23 Adhezion Biomedical, Llc Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
US11577366B2 (en) 2016-12-12 2023-02-14 Omax Corporation Recirculation of wet abrasive material in abrasive waterjet systems and related technology
US11224987B1 (en) 2018-03-09 2022-01-18 Omax Corporation Abrasive-collecting container of a waterjet system and related technology
US11452641B2 (en) 2019-06-28 2022-09-27 Ethicon, Inc. Wound closure systems for reducing surgical site infections comprising incision drapes filled with releasable antimicrobial agents
EP4004672A1 (fr) 2019-07-29 2022-06-01 Omax Corporation Mesure de débits abrasifs dans un conduit
US11624983B2 (en) 2021-08-31 2023-04-11 Macdermid Graphics Solutions, Llc Method and system for thermal processing of flexo printing elements
CN113521377B (zh) * 2021-09-13 2022-04-05 诺一迈尔(山东)医学科技有限公司 可生物降解的组织粘合剂及其制备方法
US20260115350A1 (en) * 2022-10-25 2026-04-30 Chemence Medical, Inc. Antimicrobial cyanoacrylate formulations
AU2024273514A1 (en) * 2023-05-15 2025-11-20 DAVENPORT, Thomas A Wound closure system, kits and method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US55564A (en) * 1866-06-12 Hot-air furnace
US3483870A (en) * 1963-04-22 1969-12-16 Eastman Kodak Co Surgical use of adhesive compositions
US4919939A (en) * 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
US5632727A (en) * 1988-10-03 1997-05-27 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
AU690303B2 (en) * 1994-06-28 1998-04-23 Closure Medical Corporation Ph-modified biocompatible monomer and polymer compositions
WO1996010374A1 (fr) * 1994-10-03 1996-04-11 Otogen Corporation Implants biomedicaux a biodegradabilite differentielle
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
US5569223A (en) * 1995-06-06 1996-10-29 Home Access Health Corporation Apparatus and method for enhancing blood flow to obtain a blood sample
US5684042A (en) * 1997-01-10 1997-11-04 Medlogic Global Corporation Cyanoacrylate compositions comprising an antimicrobial agent
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
AU1923199A (en) * 1997-12-17 1999-07-05 Hemodynamics, Inc. Sealing media for surgery and wound closure
US6174919B1 (en) * 1998-02-18 2001-01-16 Closure Medical Corporation Cyanoacrylate compositions with vinyl terminated ester groups
US6207193B1 (en) * 1999-12-27 2001-03-27 Stephen E. Feldman Transdermal drug delivery system

Also Published As

Publication number Publication date
EP1803473A2 (fr) 2007-07-04
EP1409033B1 (fr) 2006-12-27
EP1409033A1 (fr) 2004-04-21
US20030044380A1 (en) 2003-03-06
DE60217121T2 (de) 2007-10-25
WO2003008003A1 (fr) 2003-01-30
EP1803473B1 (fr) 2011-06-22
AU2002354960C1 (en) 2003-03-03
CA2453620A1 (fr) 2003-01-30
ATE513567T1 (de) 2011-07-15
ES2368439T3 (es) 2011-11-17
CA2453620C (fr) 2011-09-20
EP1803473A3 (fr) 2008-06-04
ATE349231T1 (de) 2007-01-15
DE60217121D1 (de) 2007-02-08
ES2279880T3 (es) 2007-09-01

Similar Documents

Publication Publication Date Title
DE60217121D1 (de) Medikament enthaltender klebstoff
DE122011100049I1 (de) Stabile pharmazeutische Losungsformulierungen fur unter Druck stehende Inhaliergerate fur die Verabreichung abgemessener Dosen.
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
DE60330322D1 (de) Arzneimittel-mikroteilchen
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
ATE316786T1 (de) Behandlung von mukositis
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
ATE507820T1 (de) Formulierungen mit kontrollierter abgabe (albuterol)
ATE420632T1 (de) Titrationsdosierschema für kontrolliert freigesetztes tramadol
DK1123120T3 (da) Medicinsk aerosolformulering
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
DE60210552D1 (de) Prozess zur Herstellung einer festen pharmazeutischen Zubereitung welche einen schwerlöslichen Wirkstoff enthält
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
MA27147A1 (fr) 4-phenyltetrahydro-isoquinoleines substituees, procede pour leur preparation, leur utilisation en tant que medicament, et medicament les contenant
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
AR013967A1 (es) UNA FORMULACION MEDICAMENTOSA PARA LA ADMINISTRACION ORAL DE PELLET DE DIFUSION CONTROLADA QUE TIENE LIBERACION CONTROLADA DE UN COMPUESTO ACTIVO QUE ES SELECCIONADO DEL ACIDO 1-CICLOPROPIL-7- [(S,S)-2,8-DIAZABICICLO [4.3.0] NON-8-IL ]-6-FLuOR-1,4-DIHIDRO-8-METOXI-4-OXO-3-QUINOLON CARBOXILICO O SALE
DE69716469D1 (de) Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
ATE286893T1 (de) 2h-1-benzopyran-derivative, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
DE60002089D1 (de) Niedrig dosierte tabletten, und verfahren zur herstellung
ATE402719T1 (de) Injiziebare pharmazeutische zusammensetzung enthaltend ethanol zur behandlung von bandscheibenvorfällen
ATE347886T1 (de) Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
PT1275383E (pt) Composicao farmaceutica de libertacao modificada que contem bupropion hc1 como substancia activa
AR033862A1 (es) Formulacion de medicamento que contiene un agente agonista muscarinico